Kenneth Rainin Foundation Awards $3 Million for Innovative Inflammatory Bowel...
OAKLAND Calif. Sept. 13 2017 PRNewswireUSNewswire The Kenneth Rainin Foundation announced today that it has awarded $3 million for Inflammatory Bowel Disease IBD research through its Innovator Awards...
View ArticleRedHill Biopharma Initiates Promotion of Esomeprazole Strontium...
Esomeprazole Strontium DelayedRelease DR Capsules 49.3 mg is an FDAapproved proprietary prescription proton pump inhibitor PPI indicated for adults for the treatment of gastroesophageal reflux disease...
View ArticleMesenchymal stem cells offer novel treatment approach for Crohn's disease...
Mary Ann Liebert Inc.Genetic Engineering News A growing body of clinical evidence shows that transplantation of a patient's own mesenchymal stem cells MSCs to achieve a cure and prevent recurrent of...
View ArticleMSC transplantation can be safe effective approach to treat Crohn's...
A growing body of clinical evidence shows that transplantation of a patient's own mesenchymal stem cells MSCs to achieve a cure and prevent recurrent of Crohn's diseaserelated fistula can be a safe and...
View ArticleBiosimilars Forum Opposes Current CMS Rule That Would Adversely Affect...
WASHINGTON Sept. 14 2017 PRNewswire Recently the Biosimilars Forum submitted comments on the Centers for Medicare & Medicaid Services' CMS proposed Medicare Physician Fee Schedule MPFS...
View ArticleSoligenix Inc SNGX Pharmaceuticals Healthcare Deals and Alliances Profile...
SummarySoligenix Inc Soligenix is a latestage biopharmaceutical company which focuses on the development of products for the treatment of serious inflammatory diseases and biodefense counter measures....
View ArticleScience Center Celebrates Immigrant Entrepreneurs in its 2017 Class of the...
The University City Science Center announced the six immigrant entrepreneurs that comprise the third class of its Innovators Walk of Fame on September 14th at its annual fundraising event Nucleus...
View ArticleMesenchymal Stem Cells Offer Novel Treatment Approach for Crohns Disease Fistula
Eurekalert &8211; A growing body of clinical evidence shows that transplantation of a patient&8217;s own mesenchymal stem cells MSCs to achieve a cure and prevent recurrent of Crohn&8217;s...
View ArticleNew TwoYear TREMFYA guselkumab Data Show Patients With Moderate To Severe...
GENEVA Sept. 16 2017 PRNewswire Janssen Research & Development LLC Janssen presented today new longerterm data from the openlabel extension of the VOYAGE 1 trial demonstrating consistent rates...
View ArticleJanssen Research and Development LLC New Twoyear Guselkumab Data Show...
GENEVA Switzerland Sept. 16 2017 PRNewswire More than 80 percent of patients receiving guselkumab including patients transitioned from HUMIRAÂ adalimumab to the antiinterleukin IL23 monoclonal antibody...
View ArticleSoligenix Announces $1.5 Million NCI SBIR Grant Award Supporting the Pivotal...
PRINCETON N.J. Sept. 18 2017 PRNewswire Soligenix Inc. Nasdaq SNGX Soligenix or the Company a latestage biopharmaceutical company focused on developing and commercializing products to treat rare...
View ArticleCrohn's & Colitis Foundation and Oxford University Press enter into...
Oxford University Press USA The Crohn's & Colitis Foundation and Oxford University Press announced today that they have entered into a new partnership to publish the Foundation's journal...
View ArticleCannabis Science Pioneer Tikun Olam Expands Partnership with MariMed to Bring...
NEWTON Mass. and NEW YORK Sept. 19 2017 PRNewswire Tikun Olam the world pioneer in cannabis research and MariMed Inc. OTCQBMRMD a preeminent management company in the U.S. medical cannabis industry...
View ArticleEnlivex Therapeutics Announces Closing of USD 8 Million Series B Round Led by...
JERUSALEM September 19 2017 PRNewswire Enlivex Therapeutics Ltd. a clinical stage immunotherapy company announced today the closing of an $8 million equity financing round at a valuation of...
View ArticleCrohn's & Colitis Foundation partners with Oxford University Press to publish...
NEW YORK Sept 19 2017 PRNewswireUSNewswire The Crohn's & Colitis Foundation and Oxford University Press announced today that they have entered into a new partnership to publish the Foundation's...
View ArticleNational Association of Specialty Pharmacy Names Ardon Health Specialty...
WASHINGTON Sept. 19 2017 PRNewswireUSNewswire Kicking off the fifth annual National Association of Specialty Pharmacy NASP meeting today outgoing NASP President Rebecca Shanahan announced the...
View ArticleCME Outfitters Offering Two New Snacks on the Use of Biosimilars in the...
Two new CME Snacks on using biosimilars to treat inflammatory disease are now available for free participation and CE credit from CME OutfittersBethesda MD PRWEB September 19 2017 CME Outfitters LLC a...
View ArticleCrohn's & Colitis Foundation Partners With Oxford University Press To Publish...
Life Sciences Jobs ...
View ArticleCrohn's & Colitis Congress offers reporters access to leading IBD research
American Gastroenterological Association The Crohn's & Colitis Foundation and the American Gastroenterological Association AGA are partnering to cosponsor the firstever Crohn's & Colitis...
View ArticleCrohn's & Colitis Foundation and Oxford University Press partner to publish...
The Crohn's & Colitis Foundation and Oxford University Press announced today that they have entered into a new partnership to publish the Foundation's journal Inflammatory Bowels Diseases beginning...
View Article